Studies from Cairo University Have Provided New Data on Computational Intelligence (Computational Intelligence Spectrophotometric Scenarios for Screening and Quantification of Single-dose Triple Therapy Banned By the World Anti-doping Agency In...).
In: Drug Week, 2024-03-19, S. 2651
serialPeriodical
Zugriff:
A report from Cairo University discusses research on computational intelligence and its application in spectrophotometric scenarios for screening and quantification of a banned triple therapy. The therapy, consisting of Atenolol, Amiloride hydrochloride, and Hydrochlorothiazide, is prohibited by the World Anti-Doping Agency due to its performance-enhancing effects and potential to mask the detection of doping drugs. The research presents innovative methods for efficient and accurate determination of the therapy, validated in compliance with guidelines. The findings suggest that these methods are suitable for routine quality control and drug screening in spiked human urine. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Studies from Cairo University Have Provided New Data on Computational Intelligence (Computational Intelligence Spectrophotometric Scenarios for Screening and Quantification of Single-dose Triple Therapy Banned By the World Anti-doping Agency In...).
|
---|---|
Zeitschrift: | Drug Week, 2024-03-19, S. 2651 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|